In non-dividing cancer cells, the AutEMsysTM therapy destabilizes microtubules, thus reducing the mobility of mitochondria and starving cells of energy. This kills these cells without surgery or infusions. 4, 5
Beyond that, the AutEMsysTM therapy benefits healthy cells by increasing their metabolic energy supply.
The AutEMsysTM can be used as a monotherapy or a complement to existing therapies.